Welcome to LookChem.com Sign In|Join Free
  • or
1-phenyl-3-(1,3-thiazol-2-yl)urea is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

14954-35-9

Post Buying Request

14954-35-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14954-35-9 Usage

Urea Derivative

The compound is derived from urea.

Contains a Phenyl Group

The presence of a phenyl group in the structure.

Contains a Thiazole Ring

The presence of a 1,3-thiazole ring in the structure.

Inhibits Thyroid Peroxidase

PTU can inhibit the enzyme responsible for thyroid hormone production.

Research Tool in Biochemistry and Pharmacology

PTU is used to study various biological processes and drug effects.

Potential Use in Hyperthyroidism Treatment

PTU may be used to treat hyperthyroidism.

Potential Use in Graves' Disease Treatment

PTU may be used to treat Graves' disease.

Potential Anti-Cancer Agent

PTU has shown promise in fighting cancer.

Anti-Inflammatory Properties

PTU has been investigated for its ability to reduce inflammation.

Anti-Fibrotic Properties

PTU has been studied for its potential to prevent tissue scarring and fibrosis.

Versatile Compound

PTU has a wide range of potential applications in medicine and biochemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 14954-35-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,9,5 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 14954-35:
(7*1)+(6*4)+(5*9)+(4*5)+(3*4)+(2*3)+(1*5)=119
119 % 10 = 9
So 14954-35-9 is a valid CAS Registry Number.

14954-35-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-phenyl-3-(1,3-thiazol-2-yl)urea

1.2 Other means of identification

Product number -
Other names 1-phenyl-3-thiazol-2-yl-urea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14954-35-9 SDS

14954-35-9Relevant academic research and scientific papers

Novel Thiazole Derivatives of Medicinal Potential: Synthesis and Modeling

Abdel-Sattar, Nour E. A.,El-Naggar, Abeer M.,Abdel-Mottaleb

, (2017/08/18)

This paper reports on the synthesis of new thiazole derivatives that could be profitably exploited in medical treatment of tumors. Molecular electronic structures have been modeled within density function theory (DFT) framework. Reactivity indices obtained from the frontier orbital energies as well as electrostatic potential energy maps are discussed and correlated with the molecular structure. X-ray crystallographic data of one of the new compounds is measured and used to support and verify the theoretical results.

Selenium-catalyzed carbonylation of 2-aminothiazole with nitro aromatics to N-aryl-N′-2-thiazolylureas

Zhang, Xiaopeng,Tang, Zhaojing,Niu, Xueli,Li, Zhengwei,Fan, Xuesen,Zhang, Guisheng

supporting information, p. 5266 - 5270 (2016/11/11)

An efficient, economical, and phosgene-free procedure for the synthesis of N-aryl-N′-2-thiazolylureas is reported. With cheap and recyclable nonmetal selenium instead of noble metals as the catalyst, carbon monoxide instead of virulent phosgene as the carbonylation agent, the selenium-catalyzed carbonylation reaction of 2-aminothiazole can proceed smoothly in one-pot manner with a variety of nitro aromatics in the presence of triethylamine to afford the desired N-aryl-N′-2-thiazolylureas mostly in moderate to good yields. Selenium catalyst can be easily recovered due to its phase-transfer catalytic ability and reused without any significant degradation of its catalytic performance.

GUANIDINE COMPOUNDS AND USE THEREOF

-

Paragraph 0170; 0171; 0172; 0173; 0174; 0175; 0176, (2017/01/02)

The present invention relates to guanidine compounds and use thereof, and more specifically, to a guanidine derivative having an excellent effect on suppressing cancer-cell proliferation, and suppressing cancer metastasis and recurrence, a method for prep

GUANIDINE COMPOUNDS AND USE THEREOF

-

Page/Page column 108; 111, (2015/11/09)

The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.

TYPE III SECRETION INHIBITORS, ANALOGS AND USES THEREOF

-

Page/Page column 88-89, (2009/12/27)

The invention, in some aspects, relates to compounds and compositions useful for inhibiting Type III secretion systems in pathogenic bacteria, such as Yersinia Pestis. In some aspects, the invention relates to methods for discovering inhibitors of the Typ

Synthesis of new unsymmetrical 4,5-dihydroxy-2-imidazolidinones. Dynamic NMR spectroscopic study of the prototropic tautomerism in 1-(2-benzimidazolyl)- 3-phenyl-4,5-dihydroxy-2-imidazolidinone

Ghandi, Mehdi,Olyaei, Abolfazl,Salimi, Farshid

, p. 768 - 775 (2007/10/03)

The acid-catalyzed cyclocondensation in refluxing acetonitrile of aqueous glyoxal with N-heteroaryl-N′-phenylureas 4a-f (heteroaryl = 2-thiazolyl, 2-pyrimidinyl, 2-pyrazinyl, 2-pyridinyl, 3-pyridinyl and 2-benzimidazolyl) led to the formation of the corre

Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging

-

, (2008/06/13)

Provided are, among other things, compounds of formula I or IA, . Also provided are methods of treatment with such compounds.

Method for treating glaucoma IIB

-

, (2008/06/13)

Provided is a method of decreasing intraocular pressure or improving ocular accommodation in an animal, including a human, comprising administering an intraocular pressure decreasing amount or ocular accommodation improving amount of a compound of the formula I or IA, wherein J is oxygen, sulfur, or N—Rd.

Study of structural parameters related to anthelminthic activity of thiazole derivatives

Walchshofer,Minjat,Tinland,et al.

, p. 59 - 64 (2007/10/02)

Thiazole derivatives were synthesized and their anthelminthic activity was tested against a nematode and cestode. The effect of electronic parameters, lipophilicity and biotransformation on activity is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 14954-35-9